J&J Investors Should Ignore The Noise Of Cancer Lawsuits For Now

8/28/17

Recently aCalifornia jury ordered Johnson & Johnson (NYSE:JNJ) to pay $471 million to a woman who claimed that using the company’s talc-based products since age 11 (like Johnson's Baby Powder) for feminine hygiene caused her to develop ovarian cancer. The ruling came from the Los Angeles Superior Court on Monday.

This suit is not the first case either because Johnson & Johnson has around 4,800 more similar claims nationwide. Furthermore, in Missouri, the company was hit with other verdicts that total over $300 million.

The reality is that, as another contributed pointed out, even if 10% of all the claims are lost in court, that would mean that the company would be liable for about $34 billion.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.